Infectious Diseases Now: Volume 52 (Issue 1 to Issue 8)
Infectious Diseases Now, previously known as Médecine et Maladies Infectieuses, is a highly regarded medical journal that publishes premier original materials, both scientific and clinical, relating to infectious pathologies and their pathogens. It operates as the official journal for the SPILF, the French Infectious Diseases Society (Société de Pathologie Infectieuse de Langue Française), emphasizing its prominence in the field of infectious diseases.
Focus and Scope:
Infectious Diseases Now addresses a multitude of infectious pathologies and their corresponding pathogens, through the publication of various scientific articles in English. The journal dives deep into multiple domains including, but not limited to, clinical studies, preventive measures, biology, nosocomial infections, epidemiology, and therapeutics. It aims to expand the understanding and knowledge of infectious diseases, contributing to advancements in the field.
Content Variety:
The journal houses a diverse array of content types, such as:
- Editorials
- Original Articles
- General Reviews
- Short Communications
- Letters to the Editor
Each issue is meticulously curated to include insights, findings, and discussions that are pivotal to the study of infectious diseases.
International Recognition:
Infectious Diseases Now has gained international recognition, being indexed in the principal international databases. This ensures its accessibility and visibility to a global audience, allowing the dissemination of pivotal findings and discussions to a wider range of professionals and scholars.
Ethical Guidelines:
The journal strictly adheres to the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals as stated by the International Committee of Medical Journal Editors (ICMJE Recommendations). It also follows the guidelines set forth by the Committee on Publication Ethics (COPE), ensuring the integrity, ethical conduct, and quality of the publications.
Target Audience:
This journal is a valuable resource for infectious disease specialists, clinicians, researchers, epidemiologists, and healthcare professionals keen on deepening their understanding and enhancing their knowledge in infectious diseases.
Conclusion:
Infectious Diseases Now stands as a pivotal source of comprehensive and top-quality content on infectious pathologies and their pathogens. By embracing a wide spectrum of studies and adhering to international ethical guidelines, the journal serves as a cornerstone for those seeking to explore the intricacies of infectious diseases. Its alignment with SPILF and international indexing accentuate its relevance and importance in the infectious diseases community, making it an essential read for professionals and scholars in the field.
Volume 52, Issue 1: Pages 1-60 (February 2022)
Volume 52, Issue 2: Pages 61-122 (March 2022)
Volume 52, Issue 3: Pages 123-182 (May 2022)
Volume 52, Issue 4: Pages 185-242 (June 2022)
Volume 52, Issue 5: Pages 243-326 (August 2022)
Volume 52, Issue 6: Pages 327-384 (September 2022)
Volume 52, Issue 7: Pages 385-420 (October 2022)
Les vaccins contre la Covid-19 : Un état des lieux
Les vaccins contre la Covid-19 : Un état des lieux
Paris
Volume 52, Issue 8, Supplement, Pages S1-S22 (November 2022)
Reviews
There are no reviews yet.